A hub for all COVID-19 vaccination certificate related information
Since the introduction of COVID-19 vaccines, many countries have begun or considering the use of COVID-19 vaccination certificates or passports as a safe passage into the new normal. By facilitating the resumption of travel and economic activities, they can play an essential role in domestic and global economic recovery. While the proposition of these instruments is attractive, countries must carefully design supporting policies such as the length of quarantine period and COVID-19 tests requirements by considering the potential costs and benefits of introducing such instruments.
To this end, in March 2021, the Health Intervention and Technology Assessment Program (HITAP), Ministry of Public Health, Thailand, and the National University of Singapore (NUS) convened a regional initiative, the COVID-19 Vaccination Policy Research and Decision Support Initiative in Asia (CORESIA): a regional study on vaccination certificates. It aims to develop guiding principles for the development and implementation of such instruments at national and regional levels by considering health, economic, social, ethical, and implementation issues.
- To develop a guidance document targeted at national and regional COVID-19 vaccine related policymakers that aims to shed light on the consideration, development, and implementation of immunity passport or certificate. This will be accompanied by a minimum dataset (MDS) that is required to develop and ensure its effectiveness in safe movement across borders.
- To establish a regional platform to monitor COVID-19 vaccination related policies, for example, immunity passport, effectiveness, coverage, adverse events, etc. The goal is not to replicate the information that is already available but rather, swiftly collate them and share with decision-makers (upon their request). In addition, through this initiative, decision-makers may be able to access information that is not yet in the public domain.
Recognising the interdisciplinary nature of these instruments, CORESIA operates through two consultation groups:
Working Group Members
The Working Group (WG) of CORESIA comprises members from 10 Asian countries with a total population of more than 3 billion. These include South Korea, China, Japan, Thailand, Malaysia, Philippines, Lao PDR, Singapore, India, and Indonesia
Dr. Auliya A. Suwantika
Prof. Gagandeep Kang
Assoc. Prof. Hsu Li Yang,
Prof. Jeonghoon Ahn
Advisory Group Members
An Advisory Group (AG) of international multi-disciplinary experts including public health, international commence, human rights, governance, and diplomacy.
Prof. David Heymann
London School of Hygiene and Tropical Medicine (LSHTM) & World Health Organization (WHO)
Dr. Derrick Heng
Ministry of Health, Singapore
Prof. George F. Gao
Chinese Center for Disease Control and Prevention & Institute of Microbiology, Chinese Academy of Sciences, China
Prof. Thiagarajan Sundararaman
National Health Systems Resource Centre (NHSRC) and People’s Health Movement (PHM), India
Dr. Kalaiarasu Peariasamy
Ministry of Health, Malaysia
Dr. Renu Madanlal Garg
Dr. Sihasak Phuangketkeow
Royal Thai Government, Thailand
Dr. Suwit Wibulpolprasert
Ministry of Public Health, Thailand
Dr. Supachai Panitchpakdi
Former United Nations and Conference on Trade and Development (UNCTAD)
CORESIA is funded by the National Research Council of Thailand (NRCT)
NRCT is a governmental organization that performs functions as specified in the Rule and Regulations for Ministry of Higher Education, Science, Research and Innovation Act B.E. 2562.
Office of the National Research Council of Thailand (NRCT) has the following missions:
1. Allocate national research and innovation funding.
2. Manage national database on science research and innovation, and indicators.
3. Initiate, drive, and coordinate national research and innovation program.
4. Formulate national research standards and ethical conducts on research.
5. Boost and transfer knowledge for the use of utmost benefits of the outcome derived from research and innovation.
6. Promote and support development of human resources on research and innovation.
7. Provide awards and recognition of research and innovation for individuals or authorities that are concerned with research and innovation.
To bolster the governmental public health response to the Coronavirus Disease 2019 (COVID-19) pandemic, NRCT has formulated research plan for National Crisis. This program provides funding to prevent, prepare for, and respond to Coronavirus Disease 2019 (COVID-19), by supporting research funding in medicine, medical equipment, epidemiological information and monitoring the effectiveness of vaccines, etc.
National Research Council of Thailand
Ministry of Higher Education, Science, Research and Innovation
Health Intervention and Technology Assessment Program (HITAP)
The Health Intervention and Technology Assessment Program (HITAP) is a semi-autonomous research unit under Thailand’s Ministry of Public Health. It was established in 2007 as a non-profit organization in order to take responsibility for appraising a wide range of health technologies and programs, including pharmaceuticals, medical devices, interventions, individual and community health promotion, and disease prevention as well as social health policy to inform policy decisions in Thailand.
In 2013, HITAP established an international unit, drawing on its experiences locally and internationally, to work at the global level with overseas development aids, international organizations, non-profit organizations, and overseas governments to build capacity for health technology assessment.
HITAP works toward creating a healthy society by producing high-quality evidence in a systematic and transparent work while advocating for public participation in the efficient and equitable allocation of limited resources in healthcare.
National University of Singapore (NUS), Saw Swee Hock School of Public Health (SSHSPH)
Building upon decades of experience in research, training and practice in epidemiology and public health, the Saw Swee Hock School of Public Health (SSHSPH), under the National University of Singapore, was established in October 2011 as Singapore’s national school of public health. The School is also a member of the National University Health System (NUHS).
The School aims to continually foster healthier communities in Singapore and the region, and impact public health programmes and policies through its robust educational programmes and translational cross-disciplinary research work on cohort studies and life course epidemiology, infectious disease research, health technology assessments, health promotion, workplace safety and health, health systems evaluation and health services research. An interdisciplinary approach, augmented by rigorous training, applicable research and regional partnerships, places SSHSPH at the forefront of public health knowledge discovery and practice in Asia.